knowledge -WSS

knowledge

author：entertainment 2025-09-30 01:02:46 - browse：7441

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Flu vaccine offering decent levels of protection this winter, new data show

WSS

Flu vaccine offering decent levels of protection this winter, new data show

International team creates first chimeric human

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Q&A: Jennifer Adair on making gene therapy available globally

MultiPlan and major insurers sued for alleged medical price

RaDonda Vaught to speak at CommonSpirit event on patient safety

entertainment

knowledge

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA does about

Bright Health sells Medicare Advantage business to Molina

Bird flu in milk supply is likely coming from asymptomatic cows

In Memoriam: Notable people who died in 2023

Q&A: Jennifer Adair on making gene therapy available globally

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pfizer highlights cancer drugs it thinks could reignite investor interest

focus

Cancer researcher Catriona Jamieson is sending tumors into space

Medical bills so high, Medicare adding extra digits to claim forms

In search for therapies for solid tumors, companies turn to claudin

Bird flu in milk supply is likely coming from asymptomatic cows

After traumatic brain injury, life support decisions can use more time

Bird flu in milk supply is likely coming from asymptomatic cows

focus

hotspot

focus

focus